NEW YORK (TheStreet) -- U.S. equities rallied higher on Monday but closed near session lows.
On CNBC’s “Fast Money” TV show, Dan Nathan, co-founder and editor of riskreversal.com, was unsure whether investors should trust this recent rally. Until the market shows more promise, he is selling the rallies.
Tim Seymour, managing partner of Triogem Asset Management, said Monday’s rally looked like a continuation of Friday's. He added the Federal Reserve is the more important market-moving component, not geopolitics.
Pete Najarian, co-founder of optionmonster.com and trademonster.com, disagreed with Seymour, saying geopolitical news is what’s moving the market right now. He added that industrial and large-cap technology stocks are doing well while financial stocks fail to rally.
Karen Finerman, president of Metropolitan Capital Advisors, said she is disappointed in the price action from the financial sector. She is taking a look at the CBOE Volatility Index (VIX.X) on the long side for portfolio protection, following its recent pullback.
Dennis Gartman, editor and publisher of The Gartman Letter, said Libya is another potential geopolitical headwind that is not on many investors’ radar. He added that it could become an issue if the country’s oil production comes offline. He is a buyer of WTI crude oil and a seller of brent crude oil, the latter of which he believes will decline over the next five to six months.
Nathan called Nuance Communications “dead money” for the time being, saying he would be a buyer at $15.
Finerman added that she is also not a buyer of Tesla based on valuation, but is not a short-seller either.
Najarian said it’s hard to buy Tesla knowing that it is not yet profitable.
CNBC’s Meg Tirrell was a guest on the show. Many Ebola treatments are in the very early stages right now, some of which haven’t even been tested on humans. Most companies have been receiving government grants to develop these treatments. The most effective way to prevent the disease, aside from vaccines -- which are being developed by companies such as GlaxoSmithKline (GSK - Get Report) and Johnson & Johnson (JNJ - Get Report) -- is through education and isolation.
Referring to Intercept Pharmaceuticals’ (ICPT - Get Report) recent earnings results, which propelled the stock higher by 66% in the after-hours session, Finerman said individual biotech stocks are too volatile for her to own. Instead, she prefers to buy the SPDR Biotech ETF (XBI - Get Report) and the iShares Nasdaq Biotechnology ETF (IBB - Get Report).
Nathan called ICPT a “no touch” on account of the fact that many investors will likely look to take profits.
JetBlue Airways (JBLU - Get Report) climbed 2% and was the first stock on the show’s “Pops & Drops” segment. Seymour said the stock has been lagging its peers for a long time and finally appears to be breaking out.
Pandora (P) popped 4%. Nathan said the stock could possibly be a takeout target. He also cited bullish call option activity in the January expiration.
King Digital Entertainment (KING) fell 6%. Najarian cited an analyst downgrade as the culprit for the selloff. However, its earnings results on Tuesday could push the stock back above $20.
Seymour said he is not bullish on gold, which has failed to rally despite all of the geopolitical unrest. The metal could be headed toward $1,100 per ounce. While he still considers small cap gold miners as “dangerous” investments, he likes select larger-cap miners such as Barrick Gold (ABX), Newmont Mining (NEM - Get Report), and Agnico Eagle Mines (AEM - Get Report).
Mark Newton, chief technical analyst at Greywolf Execution, said the S&P 500’s recent 4% pullback from the all-time highs has found support. As long as the support holds, the uptrend should continue, he added. The Industrial Select Sector SPDR ETF (XLI - Get Report) has performed relatively poor as of late, however, it appears to be stabilizing and moving higher, he concluded.
Nathan disagreed about the XLI, arguing that it may decline to $50 soon.
Seymour reasoned that many sectors, such as the industrial sector, were simply overbought and have declined to an oversold condition, causing the recent rally.
John Shahidi, co-founder and CEO of Shots, said the goal of the Shots platform is for users to only see photos of people. Users can “like” a photo, but not post comments. This is in an effort to prevent bullying, he reasoned. the company has raised $2.7 million, $1 million of which is from Justin Bieber, while the first investor was Floyd Mayweather Jr. Shots has 2 million users so far.
Seymour pointed out that Shots seems unlikely to be a takeover target since it cannot monetize its platform. Nathan added that without comments, there is no user engagement.
For their final trades — Seymour is a buyer of Yandex (YNDX - Get Report) and Finerman is a seller of ALPS Alerian MLP ETF (AMLP - Get Report). Nathan is buying AT&T (T - Get Report) and Najarian is a buyer of Hawaiian Holdings (HA - Get Report).
-- Written by Bret Kenwell in Petoskey, Mich.